The hardware and bandwidth for this mirror is donated by dogado GmbH, the Webhosting and Full Service-Cloud Provider. Check out our Wordpress Tutorial.
If you wish to report a bug, or if you are interested in having us mirror your free-software or open-source project, please feel free to contact us at mirror[@]dogado.de.

HCTR: Higher Criticism Tuned Regression

A novel searching scheme for tuning parameter in high-dimensional penalized regression. We propose a new estimate of the regularization parameter based on an estimated lower bound of the proportion of false null hypotheses (Meinshausen and Rice (2006) <doi:10.1214/009053605000000741>). The bound is estimated by applying the empirical null distribution of the higher criticism statistic, a second-level significance testing, which is constructed by dependent p-values from a multi-split regression and aggregation method (Jeng, Zhang and Tzeng (2019) <doi:10.1080/01621459.2018.1518236>). An estimate of tuning parameter in penalized regression is decided corresponding to the lower bound of the proportion of false null hypotheses. Different penalized regression methods are provided in the multi-split algorithm.

Version: 0.1.1
Depends: R (≥ 3.4.0)
Imports: glmnet (≥ 2.0-18), harmonicmeanp (≥ 3.0), MASS, ncvreg (≥ 3.11-1), Rdpack (≥ 0.11-0), stats
Published: 2019-11-22
DOI: 10.32614/CRAN.package.HCTR
Author: Tao Jiang [aut, cre]
Maintainer: Tao Jiang <tjiang8 at ncsu.edu>
License: GPL-2
NeedsCompilation: no
Materials: README
CRAN checks: HCTR results

Documentation:

Reference manual: HCTR.pdf

Downloads:

Package source: HCTR_0.1.1.tar.gz
Windows binaries: r-devel: HCTR_0.1.1.zip, r-release: HCTR_0.1.1.zip, r-oldrel: HCTR_0.1.1.zip
macOS binaries: r-release (arm64): HCTR_0.1.1.tgz, r-oldrel (arm64): HCTR_0.1.1.tgz, r-release (x86_64): HCTR_0.1.1.tgz, r-oldrel (x86_64): HCTR_0.1.1.tgz
Old sources: HCTR archive

Linking:

Please use the canonical form https://CRAN.R-project.org/package=HCTR to link to this page.

These binaries (installable software) and packages are in development.
They may not be fully stable and should be used with caution. We make no claims about them.
Health stats visible at Monitor.